Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SKILLSOFT CORP. (SKIL)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 2
  • 1 comments

Skillsoft to Report First Quarter Fiscal 2027 Financial Results on June 9

Market reaction Comment Full text

YELP INC (YELP)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 1
  • 1 comments

Yelp to Participate in the Evercore Global TMT Conference

Market reaction Comment Full text

SPRUCE BIOSCIENCES, INC. (SPRB)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 2
  • 1 comments

Spruce Biosciences to Participate in Upcoming Conferences in June

Market reaction Comment Full text

BILL HOLDINGS, INC. (BILL)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 3
  • 1 comments

BILL to Participate in Upcoming Investor Conference

Market reaction Comment Full text

TRUEBLUE, INC. (TBI)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 3
  • 1 comments

Temporary Workers Prioritize Transparency and Human Connection

Market reaction Comment Full text

BRAZE, INC. (BRZE)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 1
  • 1 comments

Braze Delivers Fourth Straight Quarter of Organic Revenue Growth Acceleration

Market reaction Comment Full text

J.JILL, INC. (JILL)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 2
  • 1 comments

J.Jill, Inc. to Report First Quarter Fiscal Year 2026 Results on June 10, 2026

Market reaction Comment Full text

NCINO, INC. (NCNO)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 3
  • 1 comments

nCino Reports First Quarter Fiscal Year 2027 Financial Results

Market reaction Comment Full text

PULSE BIOSCIENCES, INC. (PLSE)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 2
  • 1 comments

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Market reaction Comment Full text

TRAVERE THERAPEUTICS, INC. (TVTX)

  • Business News
  • May 27, 2026, 20:05 UTC
  • 1
  • 1 comments

Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in IgA Nephropathy

Market reaction Comment Full text
  • Previous
  • 1331
  • 1332
  • 1333
  • 1334
  • 1335
  • Next

Search

News categories

  • Technical Exchange News(13263)
  • Event(6229)
  • SEC News(335841)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(187035)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin